Related Experiment Video
Updated: Dec 10, 2025
06:19
Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
3.7K
Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges
Alina L Capatina1, Dimitris Lagos2,3, William J Brackenbury4,5
1Department of Biology, University of York, York, UK.
Reviews of Physiology, Biochemistry and Pharmacology
|September 1, 2020
Summary
Ion channel inhibitors show promise in cancer therapy by targeting Na+, K+, Ca2+, and Cl- channels to reduce tumor growth and metastasis. Further research is needed to overcome potential off-target effects in healthy cells.
Area of Science:
- Biomedical Science
- Oncology
- Pharmacology
Background:
- Ion channels regulate critical cancer cell functions including proliferation, motility, invasion, and metastasis.
- These channels are attractive therapeutic targets due to their plasma membrane localization and the availability of existing inhibitors.
Purpose of the Study:
- To review recent advances in ion channel inhibitors as anticancer therapeutics.
- To explore the potential of Na+, K+, Ca2+, and Cl- channel inhibitors in cancer treatment.
Main Methods:
- Review of preclinical in vitro and in vivo studies on ion channel inhibitors in cancer.
- Analysis of early-phase clinical trials for ion channel-targeting strategies.
Main Results:
- Evidence suggests various ion channel inhibitors can suppress cancer cell proliferation, migration, and invasion.
- Inhibitors may enhance apoptosis and reduce tumor growth and metastasis, potentially in combination with standard therapies.
Conclusions:
- Ion channel inhibitors represent a promising avenue for novel cancer therapeutics.
- Further research is crucial to develop effective and safe ion channel-targeting strategies, addressing potential off-target effects on normal physiological functions.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
01:26Targets for Drug Action: Overview
9.7K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.7K
01:24Non-gated Ion Channels
7.8K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
7.8K
01:19Ion Channels
90.6K
The movement of ions like sodium, potassium, and calcium into and out of the cell is essential to maintain the electrochemical gradient in living cells. The ion channels—a class of membrane transport proteins—help maintain this ionic gradient for the smooth functioning of physiological activities such as maintaining cell size and volume, conducting nerve impulses, and gas and nutrient exchange.
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
90.6K
01:30Cancer Vaccines
857
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
857
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K